Compounds > finasteride

finasteride and Urinary Bladder Neoplasms

finasteride has been researched along with Urinary Bladder Neoplasms in 16 studies

Research

Studies (16)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (12.50)18.2507
2000's1 (6.25)29.6817
2010's10 (62.50)24.3611
2020's3 (18.75)2.80

Authors

AuthorsStudies
Campbell, J; Dekalo, S; McArthur, E; Ordon, M; Power, N; Welk, B1
Cooper, RE; Dursun, F; Garg, H; Kaushik, D; Liss, MA; Pruthi, DK; Svatek, RS; Thompson, IM; Wheeler, KM1
Fradet, V; Fradet, Y; Lacombe, L; Lodde, M; McMartin, C; Toren, P1
Aboumohamed, A; Agalliu, I; Fram, E; Kovac, EZ; Sankin, AI; Schoenberg, MP; Srivastava, A; Zhu, D1
Chen, CC; Hseih, TF; Huang, CP; Shyr, CR; Tsai, YT1
Kotsar, A; Mäkelä, VJ; Murtola, TJ; Tammela, TLJ1
Fan, Y; Jarosek, SL; Konety, BR; Lawrentschuk, NL; Sathianathen, NJ1
Konety, BR; Sathianathen, NJ1
Gomella, LG1
Ankerst, DP; Grill, S; Kaushik, D; Liss, MA; Morales, EE; Svatek, RS; Thompson, IM1
La Vecchia, C1
Kim, JH; Ku, JH1
Rouprêt, M1
Barber, NJ; Donohue, JF1
Akaza, H; Imada, S; Koiso, K; Otani, M1
Akaza, H; Ami, Y; Ideyama, Y; Imada, S; Koiso, K; Takenaka, T1

Trials

2 trial(s) available for finasteride and Urinary Bladder Neoplasms

ArticleYear
Impact of Finasteride on Survival in Bladder Cancer: A Retrospective Multi-institutional Database Analysis.
    Clinical genitourinary cancer, 2023, Volume: 21, Issue:2

    Topics: Female; Finasteride; Humans; Male; Retrospective Studies; Urinary Bladder Neoplasms

2023
Finasteride does not prevent bladder cancer: A secondary analysis of the Medical Therapy for Prostatic Symptoms Study.
    Urologic oncology, 2018, Volume: 36, Issue:7

    Topics: 5-alpha Reductase Inhibitors; Androgens; Dihydrotestosterone; Finasteride; Follow-Up Studies; Humans; Male; Middle Aged; Prognosis; Prostatic Neoplasms; Urinary Bladder Neoplasms

2018

Other Studies

14 other study(ies) available for finasteride and Urinary Bladder Neoplasms

ArticleYear
5α-reductase inhibitors and the risk of bladder cancer in a large, population-based cohort.
    Urologic oncology, 2023, Volume: 41, Issue:1

    Topics: 5-alpha Reductase Inhibitors; Dutasteride; Finasteride; Humans; Male; Ontario; Oxidoreductases; Prostatic Hyperplasia; Retrospective Studies; Urinary Bladder Neoplasms

2023
Receipt of 5-Alpha Reductase Inhibitors Before Radical Cystectomy: Do They Render High-Grade Bladder Tumors Less Aggressive?
    Clinical genitourinary cancer, 2019, Volume: 17, Issue:6

    Topics: 5-alpha Reductase Inhibitors; Aged; Carcinoma, Transitional Cell; Cystectomy; Dutasteride; Finasteride; Humans; Logistic Models; Male; Margins of Excision; Neoadjuvant Therapy; Neoplasm Invasiveness; Retrospective Studies; Survival Analysis; Treatment Outcome; Urinary Bladder Neoplasms

2019
Finasteride Use and Risk of Bladder Cancer in a Multiethnic Population.
    The Journal of urology, 2021, Volume: 206, Issue:1

    Topics: 5-alpha Reductase Inhibitors; Aged; Black or African American; Finasteride; Hispanic or Latino; Humans; Male; Middle Aged; Prostatic Hyperplasia; Retrospective Studies; Risk Assessment; Urinary Bladder Neoplasms; White People

2021
The Genomic Alterations of 5α-Reductases and Their Inhibitor Finasteride's Effect in Bladder Cancer.
    Anticancer research, 2017, Volume: 37, Issue:12

    Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; 5-alpha Reductase Inhibitors; Aged; Aged, 80 and over; Case-Control Studies; Cell Line, Tumor; Cell Survival; Female; Finasteride; Genomics; Humans; Kaplan-Meier Estimate; Logistic Models; Male; Middle Aged; Urinary Bladder Neoplasms

2017
Bladder Cancer Survival of Men Receiving 5α-Reductase Inhibitors.
    The Journal of urology, 2018, Volume: 200, Issue:4

    Topics: 5-alpha Reductase Inhibitors; Aged; Cohort Studies; Dutasteride; Finasteride; Humans; Male; Retrospective Studies; Survival Rate; Urinary Bladder Neoplasms

2018
Finasteride-Nemesis of More Than 1 Urological Cancer?
    The Journal of urology, 2018, Volume: 200, Issue:4

    Topics: 5-alpha Reductase Inhibitors; Finasteride; Humans; Male; Oxidoreductases; Prostatic Hyperplasia; Prostatic Neoplasms; Urinary Bladder Neoplasms

2018
Actos, slings, finasteride, and the vaccine compensation solution.
    The Canadian journal of urology, 2013, Volume: 20, Issue:2

    Topics: Finasteride; Humans; Liability, Legal; Male; Patient Rights; Pioglitazone; Prostatic Neoplasms; Risk Assessment; Risk Factors; Suburethral Slings; Thiazolidinediones; United States; United States Food and Drug Administration; Urinary Bladder Neoplasms; Vaccines

2013
Finasteride Reduces Risk of Bladder Cancer in a Large Prospective Screening Study.
    European urology, 2016, Volume: 69, Issue:3

    Topics: 5-alpha Reductase Inhibitors; Aged; Chi-Square Distribution; Confounding Factors, Epidemiologic; Finasteride; Humans; Incidence; Male; Middle Aged; Multivariate Analysis; Proportional Hazards Models; Prospective Studies; Protective Factors; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; United States; Urinary Bladder Neoplasms

2016
Finasteride and Bladder Cancer.
    European urology, 2016, Volume: 69, Issue:3

    Topics: Enzyme Inhibitors; Finasteride; Humans; Prostatic Hyperplasia; Prostatic Neoplasms; Urinary Bladder Neoplasms

2016
Re: Edwin E. Morales, Sonja Grill, Robert S. Svatek, et al. Finasteride Reduces Risk of Bladder Cancer in a Large Prospective Screening Study. Eur Urol 2016;69:407-10.
    European urology, 2016, Volume: 69, Issue:3

    Topics: Cystectomy; Finasteride; Humans; Morale; Prospective Studies; Urinary Bladder Neoplasms

2016
Words of Wisdom. Re: Finasteride Reduces the Risk of Bladder Cancer in a Large Prospective Screening Study.
    European urology, 2016, Volume: 69, Issue:3

    Topics: Finasteride; Humans; Prospective Studies; Risk; Urinary Bladder Neoplasms

2016
How do we investigate haematuria and what role has finasteride?
    BJU international, 2004, Volume: 93, Issue:1

    Topics: Carcinoma, Transitional Cell; Enzyme Inhibitors; Finasteride; Health Care Surveys; Hematuria; Humans; Professional Practice; Referral and Consultation; Urinary Bladder Neoplasms

2004
[Effects of androgen regulation system on bladder carcinogenesis in male mice].
    Nihon Hinyokika Gakkai zasshi. The japanese journal of urology, 1995, Volume: 86, Issue:11

    Topics: 5-alpha Reductase Inhibitors; Androgen Antagonists; Animals; Butylhydroxybutylnitrosamine; Finasteride; Flutamide; Gonadotropin-Releasing Hormone; Leuprolide; Male; Mice; Mice, Inbred C3H; Orchiectomy; Urinary Bladder Neoplasms

1995
Promoting effects and mechanisms of action of androgen in bladder carcinogenesis in male rats.
    European urology, 1997, Volume: 31, Issue:3

    Topics: Administration, Oral; Androgen Antagonists; Animals; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Butylhydroxybutylnitrosamine; Carcinogens; Carcinoma; Cholestenone 5 alpha-Reductase; Disease Models, Animal; Enzyme Inhibitors; Finasteride; Flutamide; Gonadotropin-Releasing Hormone; Immunohistochemistry; Leuprolide; Male; Mice; Mice, Inbred C3H; Oxidoreductases; Rats; Rats, Wistar; Urinary Bladder Neoplasms

1997